Monday, 19 February 2018

Burn Care Market, by Type of Burn, Product Type, End User - Industry Insights, Trends, Outlook and Opportunity Analysis, 2025

Burn wounds are extremely painful, frequently highly traumatic and can lead to permanent scarring, disfigurement or even death. The management of these wounds is based on the injured area, and severity of burns and by the depth includes minor, partial and full-thickness injuries. Burn care market has witnessed various technological advancements and emerged as a standard solution to treat all degrees of burns. Conventional measures of burn care management are being rapidly replaced with advanced products due to the effectiveness of the latter for managing burn injuries, which enables faster healing. The treatment in burn injuries includes intervention therapies and use of products such as traditional and advanced care dressings. The rising number of burn injury cases rising the demand of burn care products globally. In addition to this, the unhealed burns do not only diminish quality of life but also increases the risk of infections and complications. Therefore, burn care is an important part of healing process. Moreover some serious burns may require immediate medical care to prevent further complications and death of patient.

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1279

Rising fire incidences are increasing the demand for treatment of burn injuries which in turn increasing the usage of burn care products especially in the low and middle income countries.  For instance, in January 2017 , according to the World Health Organization (WHO) data published on African Journal of Emergency Medicines, stated that burn cases accounted around 18 million disability cases and more than 2,50,000 deaths each year of which more than 90% deaths registered from low-and middle-income countries. In addition to this, U.S. fire department responded to around 1.3 million fire incidences in 2016, of which 3,280 civilian deaths and 15,700 civilian injuries reported by National Fire Protection Association (NFPA). 

Burn Care Market Taxonomy:

On the basis of depth of burn, burn care market segmented into:
  • Minor-thickness burn
  • Partial-thickness burn
  • Full- thickness burn
On the basis of product type, burn care market segmented into:
  • Traditional burn care products
  • Advanced dressing
  • Hydrogel dressing
  • Alginate dressing
  • Foam dressing
  • Hydrocolloid dressings
  • Collagen dressings
  • Other dressings
  • Biologics
  • Other burn care products
On the basis of end user, burn care market segmented into:
  • Hospitals
  • Clinics
  • Home care settings
  • Other end users
Introduction of new burn care products will favor the growth of burn care market

New product launches expected to drive the market of burn care products during the forecast period. For instance, in September 2016, ConvaTec, Inc. launched Foam Lite ConvaTec dressing after receiving the CE mark approval for management of low to non-exuding wounds such as skin tears, skin abrasions and partial thickness burns in France, Germany, the U.K., Canada, Australia and New Zealand.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/burn-care-market-1279

For instance, in July 2016, a combined team of researchers from the Boston University and Beth Israel Deaconess Medical center developed new type of hydrogel bandage for the burn patients. This new hydrogel bandage allow the easy removal at the time of dressing change, by applying an aqueous solution of cysteine methyl ester. The hydrogel bandage seals the burn wounds to prevent entry of bacteria and proven to be easily removable. Moreover the advancement in the burn care products helps to fuel the demand of burn care market.

Some of the key players in the burn care market include DeRoyal Industries, Inc., Smith & Nephew plc, Devon Medical Products, Inc., PAUL HARTMANN AG, ACell, Inc., ConvaTec Inc., Coloplast A/S, Molnlycke Health Care AB, Medela AG, Acelity L.P. Inc., Derma Sciences Inc. and Medtronic plc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Monday, 22 January 2018

Diabetes Injection Pens Market, by Product Type, Geography - Global Industry Insights, Trends, Outlook, 2025

Diabetes insulin pens are advanced forms of prefilled insulin syringes and pen needles that are used to inject insulin in the body of patients suffering from type-1 diabetes. These pens usually consist of an insulin cartridge that acts as an insulin reservoir and a dial that is used to measure the exact volume of insulin that is intended to be delivered to the patient. These cartridges and pens are available in different shapes and sizes and are also available in disposable and non-disposable types. Most of the diabetes pens are incorporated with insulin pen needles that are replaceable, thin, and extremely short to reduce the pain caused during injection. Several universal pen needles are also present in the market that fits to almost all the brands of insulin pens. These pens are handy, easy to carry around, and can be used in home settings to provide accuracy in dose delivery. This in turn, is increasing the demand for diabetes insulin pens.

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1156

Rising incidence of diabetes is expected to propel the demand for insulin injection pens

Rising incidence diabetes is one of the major factors responsible for growth of the global diabetes injection pens market. According to the American Diabetes Association, around 30.3 million of people in the U.S. suffered from diabetes, accounting for up to 9.4% of the total population in 2016. Moreover, according to the BMJ Open Diabetes Research & Care, around 387 million people in the world suffer from diabetes, out of which around 5-10% suffer from type-1 diabetes. Various other factors driving growth of the market include risk of needle-stick injuries and bacterial infection caused by regular use of syringes to inject insulin and the advancements technology related to diabetes pens, leading to development of painless devices for daily insulin injections. However, the availability of insulin patches and other substitutes for insulin delivery are expected to hamper the growth of the market.

Market Taxonomy:

On the basis of product type, the global diabetes injection pen market is segmented into:
  • Insulin Pens
  • Pen Needles
On the basis of usage, the global diabetes injection pens market is segmented into:
  • Reusable
  • Disposable
On the basis of distribution channel, the global diabetes injection pens market is segmented into:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Medical Stores
  • Diabetes Clinics
North America to hold a dominant position in the global diabetes injection pens market, owing to advancements in technology development in the in diabetes pens

On the basis of region, the global diabetes injection pens market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds the dominant position in the global diabetes injection pens market, owing to increasing prevalence of type-1 diabetes as well as development of advanced injection pens by manufacturers in the region. For instance, according to the Centers of Disease Control and Prevention (CDC), around 5% of the people suffering from diabetes are diagnosed with type-1 diabetes and are unable to produce insulin naturally. This increases the demand for external insulin administration. Moreover, according to the Juvenile Diabetes Research Foundation, the healthcare burden due to type-1 diabetes in the U.S. accounted for up to US$ 14 billion in 2016. Asia Pacific is expected to witness fastest growth in the market, owing to rising awareness among the patients as well as evolving healthcare infrastructure.

Key players are focused on development of novel products to sustain their position in the highly consolidated market

Key players operating in the global diabetes injection pens market include Novo Nordisk A/S, AstraZeneca Plc, Biocon Ltd, Eli Lilly and Company, Becton, Dickinson and Company, and Jiangsu Delfu Co. Major players are consistently focused towards innovation and development in the existing technology to maintain their significance and establish their presence in the global diabetes injection pens market. For instance, Novo Nordisk in 2014 introduced a new insulin injection pen device NovoPen Echo that was the first-ever injection pen to deliver half a unit of insulin, with a memory function that records last dose and the time passed since the last injection.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Thursday, 18 January 2018

X-ray Market to Surpass US$ 14.4 Billion Threshold by 2025 Globally

The Global X-ray Market, by Modality (Portable and Stationary), by Product Type (Rotating Anode Source, and Fix Anode Source), by Technology (Analog, Computed Technology, and Digital Radiography (Flat Panel Detectors and High Density Line Scan Solid State Detectors)), by Applications (General Radiography, Chest Imaging, Orthopedic, Cardiovascular, Dental, Mammography, and Others), by End User (Hospitals, Diagnostic Centers, Research Centers, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) was valued at US$ 7869.4 million in 2017 and is projected to exhibit a CAGR of 7.8% over the forecast period (2017 – 2025), as highlighted in a new report published by Coherent Market Insights. Increasing incidence of fractures, orthopedic disorders, and cancer as well as advancements in technology related to X-ray system, so as to improve image quality and reduce dose technique are expected to drive growth of the global X-ray market over the forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1153

X-ray is a type of electromagnetic ionizing radiation, which has wide applications in diagnostics. Advancements in technology and new product launches of innovative X-ray system are boosting growth of the market. For instance, In October 2017, Siemens Healthineers launched new Cios Spin, a mobile C-arm in the U.S. Cios Spin mobile arm provides potential benefits as a design aid intra-operative 3D imaging. Moreover, with high generative power, it can scan the solid part of the body such as the hip and can also scan more dense tissue in obese patients. Such advancements have enabled easy and immediate viewing of images on the screen, which in turn has shifted the trend from conventional X-ray techniques to digital X-ray technique, as it does not a require processing before it can be viewed. Computed tomography (CT) scans are highly valuable during emergency cases, as they provide quick information while assessing strokes, heart diseases, and brain injuries. For instance, in April 2017, Toshiba Medical launched new Aquilion Lightning computed tomography (CT), which provides high quality images and potentially helps with faster diagnosis. However, continuous exposure to the ionizing radiation, causes cell mutations, in turn leading to increased risk of cancer. This poses as a major restraint for growth of the market for X-ray.

Browse 25 Market Data Tables and 30 Figures spread through 150 Pages and in-depth TOC on X-Ray Market by Modality (Portable and Stationary), by Product Type (Rotating Anode Source, and Fix Anode Source), by Technology (Analog, Computed Technology, and Digital Radiography (Flat Panel Detectors and High Density Line Scan Solid State Detectors)), by Applications (General Radiography, Chest Imaging, Orthopedic, Cardiovascular, Dental, Mammography, and Others), by End User (Hospitals, Diagnostic Centers, Research Centers, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa) - Global Forecast to 2025

Key Takeaways of the X-ray Market:
  • The global X-ray market is expected to exhibit a CAGR of 7.8% over the forecast period (2017 – 2025), owing to the presence of high potential markets, especially in Asia Pacific, and Latin America. Whereas North America is expected to hold a dominant position in the market due to increasing problem of osteoporosis and introduction of new technologies
  • Among modalities, the portable segment is expected to gain traction over the forecast period, as portable devices reduce time spent in hospitals, resulting in lower chances of contracting hospital acquired infections (HAIs)
  • Among technologies, the digital radiography segment is expected to exhibit rapid growth, as digital radiography reduces radiation exposure and improves the ability to detect diseases
  • Among end users, the hospital segment is expected to hold the largest market share due to the increasing prevalence of cancer, fractures, and orthopedic disorders
Some major players operating in the X- ray market are Siemens AG, Toshiba Medical Systems, Hitachi Medical Corporation, Shimadzu Corporation, Carestream Healthcare, Philips Healthcare, Canon, Inc., GE Healthcare, Bracco Imaging S.p.A, and Hologic, Inc.

About CMI

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Batteries Market to Surpass US$ 3,574.9 Million Threshold by 2025 globally

The global medical batteries market by Product Type (Implantable Batteries {Pacemakers Batteries, Implantable Cardioverter Defibrillator Batteries, Neurostimulators Batteries, Cochlear Batteries, Infusion Pumps Batteries, and Other Implantable Batteries} and Non-Implantable Batteries {Diagnostic Imaging Device Batteries, Patient Monitoring Device Batteries, Critical Care Support Batteries, In Vitro Diagnostics Instrument Batteries, Therapeutic Devices, Prosthetic Device Batteries and Other Non-Implantable Batteries}), by Battery Type (Lithium Batteries, Nickel-Metal Hydride Batteries, Zinc-air batteries) and by End User (Hospitals and Nursing Homes, Clinics, Diagnostic Centers, Home Care Settings, Others) and by Region is estimated at US$ 2,181.6million in 2017 and is projected to exhibit a CAGR of 6.4 % over the forecast period (2017–2025), as highlighted in a new report published by Coherent Market Insights.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1174

Increasing prevalence of chronic diseases and cardiovascular diseases is leading to continuous developments and innovation in medical devices for treatment and prevention, such as pacemakers and defibrillators.  This rise in prevalence is leading to development of light, long-life efficient batteries, mainly in patient monitoring devices such as glucometer, hemodynamic, cardiac, neuro, fetal & neonatal, respiratory, weight, temperature, multi-parameter, and remote patient monitoring devices and this is expected to lead to growth of the medical batteries market.

Manufacturers of medical batteries are focusing on new product launches to expand its product portfolio and to cater to increasing demand for batteries. For instance, MED-EL, a provider of hearing implant systems, launched first cochlear implant audio processor to feature wireless charging, in September 2017. This wireless charging enables user to power their implants with 18 hours of battery life for each four hour charge, providing the users a full day of hearing from one overnight charge. In May 2014, Vitec Group — a manufacturer of mobile power systems for healthcare industry — introduced Elora battery system. The Elora battery system is 240Wh, lithium-ion battery, which provides flexible and scalable solutions in battery management for point-of-care technology, primarily for mobile workstations such as medical carts.

Furthermore, in October 2014, Panasonic Corporation commercialized its pin shaped lithium ion battery. The pin shaped battery is the smallest cylindrical shaped rechargeable lithium ion battery, which is suitable for powering small devices such as medical devices and wearable devices.

Browse 40 Market Data Tables and 36 Figures spread through 214 Pages and in-depth TOC on Medical devices Product Type (Implantable Batteries (Pacemakers Batteries, Implantable Cardioverter Defibrillator Batteries, Neurostimulators Batteries, Cochlear Batteries, Infusion Pumps Batteries, and Other Implantable Batteries) Non-Implantable Batteries (Diagnostic Imaging Device Batteries, Patient Monitoring Device Batteries, Critical Care Support Batteries, In Vitro Diagnostics Instrument Batteries, Therapeutic Devices, Prosthetic Device Batteries and Other Non-Implantable Batteries) by Battery Type (Lithium Batteries, Nickel-Metal Hydride Batteries, Zinc-air batteries) by End User (Hospitals and Nursing Homes, Clinics, Diagnostic Centers, Home Care Settings, Others) and by Region- Global Forecast to 2025

Manufacturers are focusing on expanding the company’s presence in the medical batteries market through mergers and acquisitions strategy, which in turn is expected to favor the growth of medical batteries in near future.  For instance, in January 2016, Ultralife Corporation acquired Accutronics Ltd. for US$ 11 million in cash transaction, as Accutronics is engaged in designing, development, and manufacturing of smart battery and charger systems for devices including digital imaging, ventilators, anesthesia, endoscopy, patient monitoring, cardio pulmonary care, oxygen concentration, and aspiration. In addition to this, in February 2017, EaglePicher Technologies, LLC acquired Lithiumstart Inc. — a company engaged in offering lithium ion battery management, safety, and power conversion technology.

Key takeaways of the market:
  • The global medical batteries market is expected to exhibit a CAGR of 6.4% over the forecast period (2017–2025), owing to the rising prevalence of cardiovascular disease. Asia Pacific market is expected to exhibit a high growth rate, in terms of value, over the forecast period, as the medical battery manufactures involved in the merger and acquisition activities to expand their market in Asia Pacific.
  • Among battery type segments, lithium batteries is expected to exhibit fastest growth with a CAGR of 7.6% over the forecast period, due to high voltage, energy density, and unique characteristics of lithium battery system makes then a strongest battery type preferred for implantable medical devices.
  • The global medical batteries market is characterized by market expansion in Asia Pacific, North America, and Europe, which is expected to generate higher market revenue due to increase in number of acquisition. For instance, EnerSys acquired the Energy Leader Batteries India Pvt Ltd. in November 2013. Moreover, the acquisitions enables EnerSys to geographically expand their medical batteries portfolio in the Asia Pacific region
Some major players operating in the medical batteries market are Ultralife Corporation, EaglePicher Technologies LLC, EnerSys, Liberating Technologies, Inc., Panasonic Corporation, Tadiran Batteries Ltd., Saft Groupe S.A., Arotech Corporation, SHENZHEN KAYO BATTERY Co., Ltd, and Vitec Group plc.

About CMI

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wednesday, 17 January 2018

Ventilators Market, by Product Type, Age Group, Interface, Mode, End User and Geography - Opportunity Analysis, by 2025

A ventilator is a medical device used to support the breathing of patients. It is a form of breathing assistance in which an endotracheal tube is directed towards the airway of patient and it is connected to ventilator system. They are often used during surgery when patient is under anesthesia, which puts a patient to sleep without interrupting normal breathing. This system can be used as a diagnostic tool to measure static compliance of airway resistance and irregular functioning of respiratory system. The failure of ventilators may result in death so it is classed as life critical system and the system should be highly reliable.

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/1220

Increase in number of private and public hospitals attributing to the growth of ventilators market

According to World Health Organization (WHO) fact sheet 2015, around 3 million people died due to of chronic obstructive pulmonary disease (COPD), accounting for 5% of all deaths. The rising incidences of chronic diseases such as chronic obstructive pulmonary diseases (COPD), bronchitis, asthma, and increase in number of accidental cases are some of the situations where medical ventilators are used. The rising incidence rate of preterm birth, respiratory diseases, growth in geriatric population associated disorders, growing pollution level, the changing lifestyle of people and habits such as smoking and drinking leading to enhanced risk of respiratory infections, lung diseases and cancer are driving the ventilators market. According to the World Health Organization (WHO), 2017, an estimated 15 million infants are born preterm annually accounting for approximately 1 million deaths in 2015. The survey also states that three-quarters of these deaths could be prevented with the current cost-effective interventions. However, the complications associated with the use of medical ventilator such as resistance from patients and physicians for technology transition, disorders such as barotrauma, lung injury, pneumonia and high cost of medical ventilators are some of the factors restraining the growth of the global ventilators market.

Global Ventilators Market Taxonomy:

The global ventilators market is segmented as per product type, age group, interface, mode, end user and region.

On the basis of product type, the global ventilators market is segmented into:
  • Portable Ventilators
  • Stationary Ventilators
On the basis of technology, the global ventilators market is segmented into:
  • Mechanical Ventilators
  • Automatic Ventilators
On the basis of age group, the global ventilators market is segmented into:
  • Adult/pediatric ventilators
  • Neonatal/infant ventilators
On the basis of interface, the global ventilators market is segmented into:
  • Invasive Ventilators
  • Non-Invasive Ventilators
On the basis of mode, the global ventilators market is segmented into:
  • Combined Mode Ventilation
  • Volume Mode Ventilation
  • Pressure Mode Ventilation
  • Others
On the basis of end user, the global ventilators market is segmented into:
  • Hospitals
  • Ambulatory Care Centers
  • Home Care Setting
North America dominates the ventilators market due to increasing incidence of coronary diseases

Regional segmentation of the global ventilators market by Coherent Market Insights comprises of North America, Latin America, Europe, Asia pacific, Middle East and Africa. North America dominates the ventilators market, followed by Europe. According to the American Heart Association, 2017, about 92.1 million American adults are suffering form of cardiovascular disease or the after-effects of stroke. According to the study conducted by Department of Anesthesiology, Columbia University, 2014, ICU occupancy ranged from 57.4% to 82.1% and the number of beds filled with mechanically ventilated patients ranged from 20.7% to 38.9% in the U.S., which is driving the growth of ventilators market in North America. Aging population, investments to curb the ventilators shortage, expansion of private hospitals in rural area, and growing economy are the some of the important factors boosting the ventilators market in Asia Pacific. According to the survey by Public Library of Science, 2016, the functional mechanical ventilators were available for only half of the ICU beds (5.1 mechanical ventilators/100,000 inhabitants) in China, indicating a relevant shortage of medical resources in the healthcare settings in China.

Major players are launching technologically advanced product to hold the major share in ventilators market

Key players operating the global ventilators market include Becton, Philips Healthcare, ResMed Inc., Medtronic Plc, Dragers Group, Smiths Group Plc, Hamilton Medical, GE Healthcare, and Teleflex Incorporated. Market players are focused on launching new product to maintain lead in the ventilator market. For instance, the medical ventilator by Smiths Medical, PNEPAC Para PAC was the recent advancement approved by the U.S. FDA in 2014, which offers greater control of breathing parameters with MRI compatibility giving maximum flexibility for transport within the medical setting. The strategies such as merger and acquisition with local and international players and focus on technological advancements are adopted by manufacturers to sustain their position in the ventilators market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wednesday, 10 January 2018

Urinary Catheters Market - By Product Type, Application, End User - Opportunity Analysis, 2025

Urinary catheter is a tube used to collect urine from the bladder. The catheters are mostly recommended by the healthcare providers for people suffering from bladder disorders such as urinary incontinence and urinary retention. The catheters are usually made of latex, silicone, and polyurethane. Foley catheter comprises a balloon for holding the tube in the bladder for long term, whereas intermittent catheters provides short term catheterization. The urinary catheters are inserted into the urethra guiding through the bladder to drain out urine providing convenience to patients post-surgery. External catheters are advanced catheters preventing catheter associated urinary tract infections (CAUTI). Urinary catheters are also used during long surgical procedures for urine drainage for patients with other medical conditions such as spina bifida, multiple sclerosis and spinal injury, as the patients with neurological disease are at a risk for neurogenic lower urinary tract dysfunction known as neurogenic bladder.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1198

Rising prevalence of benign prostate hyperplasia in adults is expected to drive the growth of globalurinary catheters market

The urinary catheters market is expected to grow drastically due to rising occurrence of target diseases such as benign prostate hyperplasia (BPH), urinary incontinence, urinary retention, bladder obstruction, and bladder cancers. According to the World Health Organization (WHO) estimates, 2015, over 200 million people are suffering from bladder control problems due to different diseases that essentially require urinary catheterization in 2015. According to the  National Association for Continence, one third of the men and women between the age group of around 55-65 years suffer from bladder control problem at some point in their adult life. Neurological disorders leading to bladder dysfunction also require catheters for urine drainage. The factors such as increasing genital surgeries, availability of improved catheters, and favorable reimbursement policies is expected to boost the market growth.

The urinary catheters market is expected to gain a significant traction over the forecast period with the launch of innovative catheters to minimize the rates of catheter associated infections. According to the study by Antimicrobial Resistance and Infection Control, 2014, catheter-acquired urinary infection is the source for about 20% health-care acquired infections in acute care facilities and over 50% in long term care facilities. In 2016, CompactCath launched smaller and discreet intermittent catheter aimed to address infection related complications and to improve self-catheterization experience.

Global Urinary Catheters Market Taxonomy:

The global urinary catheters market is segmented on the basis of product type, application, end user and geography.

On the basis of product type, the global urinary catheters market is segmented into:
  • Foley/Indwelling catheters
  • Intermittent catheters
  • External catheters
On the basis of application, the global urinary catheters market is segmented into:
  • Benign Prostate Hyperplasia
  • Urinary Incontinence
  • Urinary Retention
  • Neurogenic Bladder
  • Others
On the basis of end user, the global urinary catheters market is segmented into:
  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics
Increasing number of prostate surgeries is expected to dominate the urinary catheters market in North America

Regional segmentation of the urinary catheters market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. North America is expected to dominate the global market, owing to the rising cases of urinary continence and prostate surgeries. According to the American Academy of Family Physicians (AAFP) estimates in 2013, urinary incontinence affected approximately 20 million American women and 6 million American men with more than 250,000 surgical procedures carried out for benign prostatic hyperplasia (BPH). According to the Urology Care Foundation estimates in 2015, around 150,000 men in the U.S. undergo transurethral resection surgery of the prostate annually, thus increasing the demand for urinary catheters. In 2017, a national performance improvement program named Health Care-Associated Infections/Catheter-Associated Urinary Tract Infection was designed by the Agency for Healthcare Research and Quality Safety Program for Long-term Care to promote implementation of a CAUTI prevention program through state-based or regional collaborative in more than 500 nursing homes across the U.S.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/urinary-catheters-market-1198

Development of innovative products expanding patient choice is expected to rise the demand for urinary catheters market

Key players operating the urinary catheters market include Hollister Inc., Boston Scientific Corporation, Teleflex Inc., Coloplast, Cook Medical, B Braun Melsungen AG, and Medtronic. In 2016, Coloplast launched the new soft catheter SpeediCath Flex for men, which is designed for easy and hygienic insertion, making catheterization easy. Also, in 2015, Hollister Incorporated launched two new hydrophilic intermittent catheters, the VaPro Plus touch free and Apogee HC hydrophilic intermittent catheter. These catheters provides more options for healthcare professionals and the patients as they are easy-to-carry and store.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wednesday, 20 December 2017

Tissue Diagnostic Market by Product Type, Technology, Disease, and End User - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

Tissue diagnosis is important tool in diagnosis, monitoring, and management of different types of cancer conditions. Recognition of sign and symptoms of disease are done through biopsy, a process of taking sample from region of interest such as skin, tissue or tumor for further diagnosis. Biopsy are primarily done to look for cancer detection or to detect rejection of transplanted organ draft.

Biopsy is done to identify likely cause of cancerous and non-cancerous tissue, which are unable to detect through CT-scan or X-rays. Depending on area of sample collection various biopsy procedures are done such as endoscopic biopsy, bone marrow biopsy, skin biopsy, kidney biopsy, liver biopsy, and prostate biopsy. Furthermore biopsy can be done using needle biopsy, CT guided biopsy, Ultrasound biopsy, and surgical biopsy for the tissue diagnostic. According to the American journal of Nephrology, 2015, Australia has the highest numbers of annual renal biopsy rates (215 persons/million person/year) followed by the Finland (176 persons/million person/year) and U.S. (175 persons/million person/year). The increased numbers of biopsy procedure likely to fuel the growth of tissue diagnostic market, in near future.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/1112

Rising prevalence of different cancer incidences is major driving factor boosting the tissue diagnostic market. According to American cancer Society (ACS), 1.6 million new cases of cancer diagnosed in the U.S., in 2016. In addition, increase research funding in cancer treatment and growing healthcare expenditure likely to show gradual rise in tissue diagnostic market. National Cancer Institute, in 2015, spends US$ 4,480 million on various types of cancer research which includes breast cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, leukemia, ovarian cancer and uterine cancer.

Tissue diagnostic market taxonomy:

By Product Type:
  • Instruments
  • Tissue processors
  • Microtomes
  • Cryostats
  • Slide warmers
  • Paraffin dispenser
  • Biological microscopes
  • Embedded center modules
  • Strainers
  • Consumables
  • Stains
  • Paraffin
  • Cassettes
  • Autopsy & dissection
  • Slides
By Technology:
  • In situ hybridization
  • Digital pathology
  • Immunohistochemistry
  • Tissue microarray
  • Special staining
By Disease:
  • Breast cancer
  • Lymphoma cancer
  • Gastric cancer
  • Prostate cancer
By End user:
  • Research laboratories
  • Hospitals
  • Contract research organizations
Rise in the prevalence of cancer incidences to boost the tissue diagnostic market

According to the United States Cancer statistics report published in 2014 by Centers of Disease Control and Prevention (CDC), between 1999 and 2014, more than 1600 people a day, died due to the cause of cancer. Although screening tests helps to detect cancer condition at early stage, data from Healthy People 2020, an initiative form Department of Health and Human Services, reveals that screening rate is still below the national targets set. Combined data collected from CDC and National cancer institute (NCI) focus on the top 3 cancer incidences in male and female. In male prostate cancer incidence are higher, while in females breast cancer are most dominated, followed by lung and colon cancer respectively in both male and female.


New and advanced methods of tissue diagnosis favors the market growth

Innovation in tissue diagnostic process for the efficient diagnostic testing such as Fluorescence in situ hybridization (FISH), Immunohistochemistry (IHC) and In situ hybridization (ISH) raises the opportunity to grow tissue diagnostic market in future. In September 2017, researchers at the University of Texas, developed a new way of diagnosis by creating pen named as “MasSpec Pen”, which is handheld devices able to distinguish healthy tissue and tumor tissue in just 10 seconds, more than 150 times quicker than existing technology. These new tool provides improvement in cancer treatment and minimizes the chances of recurrence by offering precise diagnostic information, which eventually favors the growth in tissue diagnostic market.

Key players operated in the tissue diagnostic market are Biocare Medical, Agilent technologies, Thermo Fisher Scientific, Sigma-Aldrich, Roche Diagnostics, Danaher corp., Biogenex Laboratories, Life Technologies and Abbott laboratories.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.